Key facts
- Piraeus Medical’s last known valuation is $12.5M (Feb 2025).
- It has raised $12.6M across 7 recorded rounds; the latest was Seed Round ($3.6M) in Mar 2026.
- 1 investment vehicle was formed to buy Piraeus Medical shares in the last 12 months, reporting $2.2M sold to 14 investors, per SEC Form D filings.
- Piraeus Medical has filed 9 Form Ds with the SEC since 2022, most recently Sep 2025 ($300K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 7 rounds
- ·Watchlist + deal alerts for Piraeus Medical
Funding rounds
7 roundsSecondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Piraeus Medical shares, reporting $2.2M sold to 14 investors. Most recent filing Apr 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Piraeus Medical
Manufacturer of medical equipment based in Maple Grove, New York. The company offers various types of medical and healthcare instruments that are used at ease from home, enabling patients the chance to spend time with their families.
- Sector
- Healthcare
- HQ
- Maple Grove, MN, United States
- Founded
- 2021
- Employees
- 9
- Website
- piraeusmedical.com/
- Ownership
- Privately Held (backing)
Piraeus Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Piraeus Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Piraeus Medical in its N-PORT filings yet. We sweep new filings monthly.